Multi Point Pacing and Continuous Atrioventricular Conduction OPtimization of Cardiac Resynchronization Therapy - PPAP-CRT

Kusano Kengo0 个研究点目标入组 50 人开始时间: 2021年9月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. A patient who has never received CRT
•2. A patient who is eligible for CRT according to the guideline of The Japanese Circulation Society(JCS) and scheduled for implantation of CRT-D
•3. A patient with a fixed residence who can follow the scheduled follow-up
•4. A patient who has signed and dated the informed consent

•1. A patient who is suffering from AV block (excluding atrial conduction time 250 ms or more)
•2. A patient who is suffering from chronic atrial fibrillation
•3. A patient who underwent tricuspid valve surgery or has tricuspid cardiac surgery planned
•4. A patients who has a life expectancy of less than 2 years with a non-cardiac cause
•5. A patient who is pregnant, breastfeeding or may become pregnant
•6. A patient who is less than 20 years of age at the time of consent
•7. A patient who is already included or will enroll in another interventional study during this study
•8. A patient who is judged by the Principal Investigator (PI) or the Sub-Investigator (SI) as ineligible for participation in this study due to another reason

发起方

Kusano Kengo